COVID-19 has uncovered a big problem in the pharmaceutical marketplace: traditional commercial forecasting methods can't adapt fast enough in times of rapid change. Today, forecasters are overwhelmed by constantly shifting information and a barrage of new questions from senior leaders. But with the right approach, forecasters can become a pharma company's "first responders", helping their company understand the shifting marketplace to act decisively. Read our latest whitepaper to learn more